Radiopharm Theranostics Limited Sponsored ADR’s (RADX) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting Radiopharm Theranostics Limited Sponsored ADR is a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 20-Day exponential moving average is 0.96, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $0.76, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 50-Day exponential moving average is 1.37, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $0.76, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 10-Day exponential moving average is 0.86, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $0.76, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 100-Day exponential moving average is 2.10, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $0.76, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) stock price is $0.76 and Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 50-day simple moving average is 1.29, creating a Sell signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) stock price is $0.76 and Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 100-day simple moving average is 2.32, creating a Sell signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) stock price is $0.76 and Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 200-day simple moving average is 3.47, creating a Sell signal.